| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 27 May 2025 | 17 May 2025 |
| Link Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve Audited financial results for the quarter and financial year ended on March 31 2025 under Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Outcome of Board Meeting held on 27th May, 2025. (As Per BSE Announcement Dated on :27.05.2025) | ||
| Board Meeting | 7 Feb 2025 | 28 Jan 2025 |
| LINK PHARMA CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve The unaudited financial results of the Company for the quarter and nine months ended on December 31 2024. Unaudited Financial Results for the quarter and half year ended on December 31, 2024. (As per BSE Announcement Dated on 07/02/2025) | ||
| Board Meeting | 11 Nov 2024 | 30 Oct 2024 |
| LINK PHARMA CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve Unaudited Financial results for the quarter and half year ended on September 30 2024. Pursuant to Regulations 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company, at its Meeting held on today, i.e. Monday 11th November, 2024 approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2024 along with the Limited Review Report of the Statutory Auditors. Read less.. (As Per BSE Announcement Dated on 11.11.2024) | ||
| Board Meeting | 9 Aug 2024 | 2 Aug 2024 |
| LINK PHARMA CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve unaudited quarterly financial results for the quarter ended 30.06.2024. Outcome of Board Meeting held on 09th August, 2024 . We herewith submit unaudited financial results for the quarter ended 30th June, 2024. (As Per BSE Announcement Dated on 09.08.2024) | ||
| Board Meeting | 25 Jul 2024 | 15 Jul 2024 |
| LINK PHARMA CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2024 inter alia to consider and approve Re-classification of status of shareholder from Promoter Group category to Public category under the SEBI (LODR) Regulations 2015. Outcome for board meeting in the matter of Reclassification was subject to the approval of the other regulatory authorities, in terms of Regulation 31A of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and amendments thereof. (As per BSE Announcement Dated on 25/07/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.